Literature DB >> 22184406

Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.

Kai Sun1, Maite Alvarez, Erik Ames, Isabel Barao, Mingyi Chen, Dan L Longo, Doug Redelman, William J Murphy.   

Abstract

Natural killer (NK) cells can mediate the rejection of bone marrow allografts and exist as subsets based on expression of inhibitory/activating receptors that can bind MHC. In vitro data have shown that NK subsets bearing Ly49 receptors for self-MHC class I have intrinsically higher effector function, supporting the hypothesis that NK cells undergo a host MHC-dependent functional education. These subsets also play a role in bone marrow cell (BMC) allograft rejection. Thus far, little in vivo evidence for this preferential licensing across mouse strains with different MHC haplotypes has been shown. We assessed the intrinsic response potential of the different Ly49(+) subsets in BMC rejection by using β2-microglobulin deficient (β2m(-/-)) mice as donors. Using congenic and allogeneic mice as recipients and depleting the different Ly49 subsets, we found that NK subsets bearing Ly49s, which bind "self-MHC" were found to be the dominant subset responsible for β2m(-/-) BMC rejection. This provides in vivo evidence for host MHC class I-dependent functional education. Interestingly, all H2(d) strain mice regardless of background were able to resist significantly greater amounts of β2m(-/-), but not wild-type BMC than H2(b) mice, providing evidence that the rheostat hypothesis regarding Ly49 affinities for MHC and NK-cell function impacts BMC rejection capability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184406      PMCID: PMC3286220          DOI: 10.1182/blood-2011-08-374314

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

2.  Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.

Authors:  A Raziuddin; D L Longo; L Mason; J R Ortaldo; W J Murphy
Journal:  Int Immunol       Date:  1996-12       Impact factor: 4.823

Review 3.  Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors.

Authors:  D H Raulet; W Held; I Correa; J R Dorfman; M F Wu; L Corral
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

4.  Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice.

Authors:  M Salcedo; M Andersson; S Lemieux; L Van Kaer; B J Chambers; H G Ljunggren
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

Review 5.  Biology and genetics of hybrid resistance.

Authors:  M Bennett
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

Review 6.  Natural killer cell receptors.

Authors:  W M Yokoyama
Journal:  Curr Opin Immunol       Date:  1995-02       Impact factor: 7.486

7.  Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule.

Authors:  H Jiang; R Ware; A Stall; L Flaherty; L Chess; B Pernis
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

8.  T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.

Authors:  C J Aldrich; R Waltrip; E Hermel; M Attaya; K F Lindahl; J J Monaco; J Forman
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

9.  An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.

Authors:  W J Murphy; V Kumar; J C Cope; M Bennett
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

10.  Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).

Authors:  R E Vance; J R Kraft; J D Altman; P E Jensen; D H Raulet
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  21 in total

1.  Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.

Authors:  Antonio Pierini; Lucrezia Colonna; Maite Alvarez; Dominik Schneidawind; Hidekazu Nishikii; Jeanette Baker; Yuqiong Pan; Mareike Florek; Byung-Su Kim; Robert S Negrin
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

2.  Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Authors:  Daniel M Andrews; Lucy C Sullivan; Nikola Baschuk; Christopher J Chan; Richard Berry; Claire L Cotterell; Jie Lin; Heloise Halse; Sally V Watt; Jennifer Poursine-Laurent; Chyung-Ru Wang; Anthony A Scalzo; Wayne M Yokoyama; Jamie Rossjohn; Andrew G Brooks; Mark J Smyth
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

3.  Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.

Authors:  Michael D Bern; Diana L Beckman; Takashi Ebihara; Samantha M Taffner; Jennifer Poursine-Laurent; J Michael White; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

Review 4.  Innate immune cells in transplantation.

Authors:  Jessica H Spahn; Wenjun Li; Daniel Kreisel
Journal:  Curr Opin Organ Transplant       Date:  2014-02       Impact factor: 2.640

5.  Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.

Authors:  Can M Sungur; Yajarayma J Tang-Feldman; Erik Ames; Maite Alvarez; Mingyi Chen; Dan L Longo; Claire Pomeroy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

6.  Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study.

Authors:  Jessica P Hwang; Aimee K Roundtree; Sergio A Giralt; Maria Suarez-Almazor
Journal:  BMJ Support Palliat Care       Date:  2012-08-03       Impact factor: 3.568

7.  Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.

Authors:  Maite Alvarez; Kai Sun; William J Murphy
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

Review 8.  Advantages and clinical applications of natural killer cells in cancer immunotherapy.

Authors:  Erik Ames; William J Murphy
Journal:  Cancer Immunol Immunother       Date:  2013-08-30       Impact factor: 6.968

Review 9.  Positive and negative regulation by NK cells in cancer.

Authors:  Can M Sungur; William J Murphy
Journal:  Crit Rev Oncog       Date:  2014

10.  Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.

Authors:  Maite Alvarez; Can M Sungur; Erik Ames; Stephen K Anderson; Claire Pomeroy; William J Murphy
Journal:  J Immunol       Date:  2013-06-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.